TREATMENT OF BRONCHIAL ASTHMA (TAMAKA SHWASA)THROUGH AYURVEDA

CLINICAL EVALUATION OF SINGHYADI KWATHA IN THE MANAGEMENT OF TAMAKA SWASA (BRONCHIAL ASTHMA)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045874

Enrollment

Registered

2022-09-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.PATIENTS HAVING CHRONICITY BELOW 10 YEARS 2. PATIENTS WHO ARE PRESENTING WITH CLINICAL FEATURES OF TAMAKA SWASA (BRONCHIAL ASTHMA OR ALLERGIC BRONCHIAL ASTHMA) LIKE, BREATHLESSNESS, WHEEZE, PAROXYSM OF ATTACK, COUGH ETC. IRRESPECTIVE OF SEX AND RELIGION

Exclusion criteria

Exclusion criteria: a) Age below 10 and above 70 years. b) Patients having asthma due to secondary causes such as drug induced like aspirin. c) Pregnant women and lactating mothers. d) Systemic illness like Tuberculosis, Carcinoma, Endocrine disorders e) Patient having Clinical Features of CCF. f) Patient having the major renal or liver disorders.

Design outcomes

Primary

Measure	Time frame
Effectiveness of Singhyadi Kwatha in the management of Tamaka Shwasa of various etiological factors.Timepoint: 45 DAYS for each patients and completion of trial within 6 months from the date of starting of trial (1st October 2022)	—

Secondary

Measure	Time frame
To evaluate the safety, sustainability and adverse drug reaction of trial drug.Timepoint: 45 DAYS	—

Countries

India

Contacts

Public ContactDr SUMIT PRAJAPAT

UNIVERSITY POST GRADUATE INSTITUTE OF AYURVED STUDIES AND RESEARCH JODHPUR

drpramodmishra4@gmail.com9001009793

Outcome results